查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1483138

动物杀寄生虫剂市场评估：依寄生虫类型、动物类型、药物类型、最终用户和地区划分的机会和预测（2017-2031）

Animal Parasite Treatment Market Assessment, By Parasite Type, By Animal Type, By Treatment Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 232 Pages | 商品交期: 3-5个工作天内

价格

全球兽用寄生虫剂市场规模将从2023年的102.7亿美元成长到2031年的168.1亿美元，预计2024-2031年期间复合年增长率为6.35%。

各种体内寄生虫和体外寄生虫的威胁日益增加，以及人们对治疗解决方案的认识不断提高，正在推动全球动物杀虫剂市场的发展。内部和外部寄生虫都会削弱免疫系统并引起疾病。因此，对各种处理解决方案的需求不断增加，以确保消除寄生威胁。此外，由于动物产品的高营养价值，世界不同地区对动物产品的消费不断增加，也推动了对动物寄生虫解决方案的需求。牛肉和鸡肉等非素食成分含有 B 群维生素、蛋白质、锌、镁和铁，这对于确保骨骼、软骨和肌肉的强度以及荷尔蒙和酵素的最佳产生至关重要。

此外，成功的收购也推动了市场成长。收购使公司能够透过丰富产品组合併获得服务更广泛客户群的能力来扩大客户群。2021 年 11 月，NEOGEN Corporation宣布收购以提供多种宠物药品而闻名的 CAPInnoVet, Inc.。此次收购扩大了 Neogen 的能力，并使其能够策略性地进入杀寄生虫剂市场。

宠物拥有量的增加推动了全球动物杀虫剂市场：

宠物数量的增加是全球动物杀虫剂市场的主要趋势之一。由于城市化的进步和核心家庭的趋势，人们越来越喜欢饲养宠物。《Forbes》估计，过去几年美国的宠物拥有量大幅增加，预计到 2024 年，美国约有 66% 的家庭将拥有宠物。人们对各种治疗解决方案的可用性的认识不断提高，以及保护伴侣动物免受痛苦和疾病的愿望不断增强，正在促使宠物主人购买各种兽用杀虫剂。此外，不需要频繁给药的治疗方法的开发也推动了市场的扩张，因为此类治疗方法因其便利性而受到越来越多的青睐。

该报告调查了全球动物寄生虫杀剂市场，并提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构以及影响市场成长的因素。

目录

第一章研究方法论

第二章 专案范围与定义

第三章执行摘要

第四章 全球动物寄生虫剂市场展望

  • 市场规模/预测
  • 依寄生虫类型
    • 体内寄生虫
    • 体外寄生虫
  • 依动物类型
    • 食用动物
    • 宠物
    • 其他
  • 依药物类型
    • 外寄生虫剂
    • 体内杀虫剂
    • 端面
  • 依最终用户
    • 动物农场
    • 动物医院/诊所
    • 居家护理
  • 依地区
    • 北美
    • 南美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 依公司划分的市场占有率

第五章全球动物寄生虫杀剂市场展望：依地区

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 6 章 市场测绘，2023 年

  • 依寄生虫类型
  • 依动物类型
  • 依药物类型
  • 依最终用户
  • 依地区

第七章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第八章市场动态

  • 生长促进因子
  • 生长抑制因素（问题/限制）

第九章 监理架构与创新

  • 专利情况
  • 创新/新兴技术

第十章 主要公司情况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 名市场领导者的市场收入分析
  • 併购/合资（如适用）
  • SWOT分析（5家参与企业）

第11章价格分析

第十二章案例研究

第十三章 主要参与者展望

  • Bayer AG
  • Zoetis Inc.
  • Virbac Group
  • Merck & Co., Inc.
  • Ceva Sante Animale
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Vetoquinol Group
  • PetIQ, LLC
  • Bimeda Holdings Limited

第十四章 战略建议

第十五章关于我们公司/免责声明

Product Code: MX11375

Global animal parasite treatment market is projected to witness a CAGR of 6.35% during the forecast period 2024-2031, growing from USD 10.27 billion in 2023 to USD 16.81 billion in 2031F. The growth of the market is boosted by increasing consumption of animal derived products, rising popularity of pet adoption, and novel product launches and strategic collaborations.

The growing threat of various endoparasites and ectoparasites and increasing awareness about the treatment solutions drive the global animal parasite treatment market. Both internal and external parasites can weaken the immune system and cause diseases. Thus augmenting the requirement for different treatment solutions in order to ensure that the threat of parasites can be contained. Additionally, the growing consumption of animal-based products in various regions across the globe due to their high nutritional value is also increasing the demand for animal parasite treatment solutions. Non-vegetarian sources of foods such as beef and poultry include vitamin B, protein, zinc, magnesium, and iron, which are essential for ensuring the strength of bones, cartilage, and muscles and ensuring optimal production of hormones and enzymes.

Additionally, successful acquisitions are also bolstering the growth of the market as they allow companies to enhance their product portfolios and expand their customer base by gaining the ability to cater to a broad clientele. In November 2021, NEOGEN Corporation announced the acquisition of CAPInnoVet, Inc. a company known for providing various pet medications. The transaction expanded NEOGEN's capabilities and allowed them to enter the parasiticide market strategically.

Increasing Pet Adoption is Driving the Global Treatment Market for Animal Parasite

The rise of pet adoption is one of the major global animal parasite treatment market trends. The increasing preference for pet adoption can be attributed to increasing urbanization and the growing popularity of nuclear households. Pet parents have a vested interest in the health and well-being of their pets and ensure that the pets are provided with high-quality care and treatments. As per the estimates of Forbes, pet ownership in the United States has significantly increased over the past few years, and it is estimated that in 2024, approximately 66% of the households in the country own a pet. The growing awareness about the availability of various treatment solutions, coupled with the increasing preference for protecting companion animals from distress and diseases, is encouraging pet owners to spend on various animal parasite treatments. Additionally, the development of treatments that do not require frequent administration is also driving the expansion of the market as preference for such treatment options is increasing due to their convenience.

Introduction of Novel Products is Boosting Global Animal Parasite Treatment Market Demand

The growing emphasis on novel product development and launches is one of the major drivers of the market. In 2022, Vetoquinol launched Felpreva, the first spot-on parasiticide for felines that is capable of treating both external and internal parasite infections and infestations. The three-month spot-on parasiticide belongs to the bispyrazole chemical family and is effective against mites, fleas, and ticks as well as hookworms, lungworms, and roundworms. Meanwhile, in April 2024, Boehringer Ingelheim, one of the global leaders in animal health, announced that they are launching NexGard SPECTRA (milbemycin oxime and afoxolaner) in India. The new flavorful product launched by the company offers a broad spectrum of ecto- and endo-parasite control. This prescription-only product provides comprehensive protection with the help of a single monthly chewable, reducing the burden of treatment on animal owners and caretakers. Such developments and product launches increase the convenience of the care providers and allow companies to expand their customer base, boosting market growth.

North America Holds Significant Share in the Global Animal Parasite Treatment Market

The growth of the market in North America can be attributed to the strong presence of various key market players, the rise of pet adoption in the United States of America and Canada and increasing awareness about the various parasites and their treatments. The rising adoption of companion animals in the region can be attributed to the growing awareness about the various emotional benefits provided by them. The growing adoption of companion animals is supported by a rise in mental health conditions. The Progressive Animal Welfare Services (PAWS) estimates that one in five Canadians live with some form of mental illness. The Mental Health Commission of Canada estimates that approximately 23% of the country's population will be suffering from some mental illness by 2041. Several studies show a strong correlation between adopting a pet and improved mental health, with many emphasizing the mental health benefits of pet ownership. Pets, such as dogs and cats, provide companionship, unconditional love, and emotional support, which can alleviate feelings of loneliness, reduce stress, and boost mood.

Ectoparasiticides Are Expected to Witness Increase in Demand

The rising threat of ticks, mites, and fleas is boosting the demand for ectoparasiticides globally. Ectoparasites affect the skin of animals and can impact the production of animal products such as wool, silk, leather, and many others. The usage of ectoparasiticides is regulated by various governing bodies in different countries. In the United States, the use of ectoparasiticides is regulated by EPA (Environmental Protection Agency). Pour-ons are considered to be more effective against lice infestations (Haematopinus and Linognathus) as compared to equivalent compounds that are administered parenterally. This large consumption of animal-based products, including milk and meat, in various regions across the globe due to the various nutritional benefits offered by the food substances is augmenting the utilization of ectoparasiticides by cattle owners.

Future Market Scenario (2024-2031F)

As per the global animal parasite treatment market analysis, the market demand is expected to witness a significant increase owing to the rise in pet adoption, growing awareness about the various parasite treatment options and their preventive measures, increasing requirement for eco-friendly treatment options, and increasing collaborations to support novel product development. The requirement for treatment solutions that offer efficacy for longer periods of time is expected to rise as they aid in reducing the burden of treatment on livestock and pet owners. Additionally, due to the growing threat of climate change, a shift in preference for eco-friendly solutions is being witnessed across various industries, including animal parasite treatments. Thus, efforts towards the development of eco-friendly treatment solutions are increasing. Partnerships between various organizations are expected to boost such developments. For instance, the partnership between the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and Boehringer Ingelheim is expected to bolster the development of parasiticides.

Key Players Landscape and Outlook

Some of the leading players operating in the global animal parasite treatment market are Bayer AG, Zoetis Inc., Virbac Group, Merck & Co., Inc., and Elanco Animal Health Incorporated. The increasing efforts by various market players towards the development and launch of novel products are providing lucrative growth opportunities to the market. In 2023, Zoetis Inc. introduced the Valcor injectable, the first dual-active endectocide that will be available by prescription in the United States. The product received approval for use in replacement dairy heifers that are younger than twenty months and in beef cattle that are two months and older. The product has been designed to address 35 external and internal parasites. Valcor is also indicated for treating and controlling eyeworms and lungworms, among others, and contains two active ingredients that are responsible for causing parasite paralysis and death. Levamisole stimulates worm muscles, whereas Doramectin modulates chloride ion channel activities in the nervous system of orthopods and nematodes by inhibiting the electrical activity of nerve cells. The development of such products is expected to aid the market players in expanding their customer base and provide lucrative growth opportunities to the market in the forecast period.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Animal Parasite Treatment Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
  • 4.2.By Parasite Type
    • 4.2.1.Endoparasites
      • 4.2.1.1.Tapeworm
      • 4.2.1.2.Roundworm
      • 4.2.1.3.Flukes
      • 4.2.1.4.Protozoans of Vertebrates
      • 4.2.1.5.Others
    • 4.2.2.Ectoparasites
      • 4.2.2.1.Ticks
      • 4.2.2.2.Fleas
      • 4.2.2.3.Lice
      • 4.2.2.4.Mites
      • 4.2.2.5.Parasitic Flies
      • 4.2.2.6.Others
  • 4.3.By Animal Type
    • 4.3.1.Food Producing Animals
      • 4.3.1.1.Poultry
      • 4.3.1.2.Cattle
      • 4.3.1.3.Sheep and Goats
      • 4.3.1.4.Swine
      • 4.3.1.5.Others
    • 4.3.2.Companion Animals
      • 4.3.2.1.Dogs
      • 4.3.2.2.Felines (Cat Family)
      • 4.3.2.3.Others
    • 4.3.3.Other Livestock
  • 4.4.By Treatment Type
    • 4.4.1.Ectoparasiticides
      • 4.4.1.1.Pour On
      • 4.4.1.2.Spray
      • 4.4.1.3.Spot On
      • 4.4.1.4.Powder
      • 4.4.1.5.Collars
      • 4.4.1.6.Others
    • 4.4.2.Endoparasiticides
      • 4.4.2.1.Tablets
      • 4.4.2.2.Liquids
      • 4.4.2.3.Injectables
      • 4.4.2.4.Feed Additives
      • 4.4.2.5.Others
    • 4.4.3.Endectocides
  • 4.5.By End-user
    • 4.5.1.Animal Farms
    • 4.5.2.Veterinary Hospitals and Clinics
    • 4.5.3.Homecare Settings
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.South America
    • 4.6.3.Europe
    • 4.6.4.Asia-Pacific
    • 4.6.5.Middle East and Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Animal Parasite Treatment Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
    • 5.1.2.By Parasite Type
      • 5.1.2.1.Endoparasites
        • 5.1.2.1.1.Tapeworm
        • 5.1.2.1.2.Roundworm
        • 5.1.2.1.3.Flukes
        • 5.1.2.1.4.Protozoans of Vertebrates
        • 5.1.2.1.5.Others
      • 5.1.2.2.Ectoparasites
        • 5.1.2.2.1.Ticks
        • 5.1.2.2.2.Fleas
        • 5.1.2.2.3.Lice
        • 5.1.2.2.4.Mites
        • 5.1.2.2.5.Parasitic Flies
        • 5.1.2.2.6.Others
    • 5.1.3.By Animal Type
      • 5.1.3.1.Food Producing Animals
        • 5.1.3.1.1.Poultry
        • 5.1.3.1.2.Cattle
        • 5.1.3.1.3.Sheep and Goats
        • 5.1.3.1.4.Swine
        • 5.1.3.1.5.Others
      • 5.1.3.2.Companion Animals
        • 5.1.3.2.1.Dogs
        • 5.1.3.2.2.Felines (Cat Family)
        • 5.1.3.2.3.Others
      • 5.1.3.3.Other Livestock
    • 5.1.4.By Treatment Type
      • 5.1.4.1.Ectoparasiticides
        • 5.1.4.1.1.Pour On
        • 5.1.4.1.2.Spray
        • 5.1.4.1.3.Spot On
        • 5.1.4.1.4.Powder
        • 5.1.4.1.5.Collars
        • 5.1.4.1.6.Others
      • 5.1.4.2.Endoparasiticides
        • 5.1.4.2.1.Tablets
        • 5.1.4.2.2.Liquids
        • 5.1.4.2.3.Injectables
        • 5.1.4.2.4.Feed Additives
        • 5.1.4.2.5.Others
      • 5.1.4.3.Endectocides
    • 5.1.5.By End-user
      • 5.1.5.1.Animal Farms
      • 5.1.5.2.Veterinary Hospitals and Clinics
      • 5.1.5.3.Homecare Settings
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
        • 5.1.6.1.1.By Value
      • 5.1.6.2.By Parasite Type
        • 5.1.6.2.1.Endoparasites
          • 5.1.6.2.1.1.Tapeworm
          • 5.1.6.2.1.2.Roundworm
          • 5.1.6.2.1.3.Flukes
          • 5.1.6.2.1.4.Protozoans of Vertebrates
          • 5.1.6.2.1.5.Others
        • 5.1.6.2.2.Ectoparasites
          • 5.1.6.2.2.1.Ticks
          • 5.1.6.2.2.2.Fleas
          • 5.1.6.2.2.3.Lice
          • 5.1.6.2.2.4.Mites
          • 5.1.6.2.2.5.Parasitic Flies
          • 5.1.6.2.2.6.Others
      • 5.1.6.3.By Animal Type
        • 5.1.6.3.1.Food Producing Animals
          • 5.1.6.3.1.1.Poultry
          • 5.1.6.3.1.2.Cattle
          • 5.1.6.3.1.3.Sheep and Goats
          • 5.1.6.3.1.4.Swine
          • 5.1.6.3.1.5.Others
        • 5.1.6.3.2.Companion Animals
          • 5.1.6.3.2.1.Dogs
          • 5.1.6.3.2.2.Felines (Cat Family)
          • 5.1.6.3.2.3.Others
          • 5.1.6.3.2.4.Other Livestock
      • 5.1.6.4.By Treatment Type
        • 5.1.6.4.1.Ectoparasiticides
          • 5.1.6.4.1.1.Pour On
          • 5.1.6.4.1.2.Spray
          • 5.1.6.4.1.3.Spot On
          • 5.1.6.4.1.4.Powder
          • 5.1.6.4.1.5.Collars
          • 5.1.6.4.1.6.Others
        • 5.1.6.4.2.Endoparasiticides
          • 5.1.6.4.2.1.Tablets
          • 5.1.6.4.2.2.Liquids
          • 5.1.6.4.2.3.Injectables
          • 5.1.6.4.2.4.Feed Additives
          • 5.1.6.4.2.5.Others
        • 5.1.6.4.3.Endectocides
      • 5.1.6.5.By End-user
        • 5.1.6.5.1.Animal Farms
        • 5.1.6.5.2.Veterinary Hospitals and Clinics
        • 5.1.6.5.3.Homecare Settings
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Parasite Type
  • 6.2.By Animal Type
  • 6.3.By Treatment Type
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat From New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Bayer AG
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Zoetis Inc.
  • 13.3.Virbac Group
  • 13.4.Merck & Co., Inc.
  • 13.5.Ceva Sante Animale
  • 13.6.Boehringer Ingelheim International GmbH
  • 13.7.Elanco Animal Health Incorporated
  • 13.8.Vetoquinol Group
  • 13.9.PetIQ, LLC
  • 13.10.Bimeda Holdings Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 3.Global Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 4.Global Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 5.Global Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 6.Global Animal Parasite Treatment Market Share (%), By Region, 2017-2031F
  • Figure 7.North America Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 8.North America Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 9.North America Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 10.North America Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 11.North America Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 12.North America Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
  • Figure 13.United States Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 14.United States Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 15.United States Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 16.United States Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 17.United States Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 18.Canada Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 19.Canada Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 20.Canada Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 21.Canada Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 22.Canada Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 23.Mexico Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 24.Mexico Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 25.Mexico Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 26.Mexico Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 27.Mexico Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 28.Europe Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 29.Europe Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 30.Europe Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 31.Europe Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 32.Europe Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
  • Figure 34.Germany Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 35.Germany Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 36.Germany Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 37.Germany Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 38.Germany Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 39.France Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 40.France Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 41.France Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 42.France Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 43.France Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 44.Italy Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 45.Italy Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 46.Italy Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 47.Italy Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 48.Italy Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 49.United Kingdom Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 50.United Kingdom Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 51.United Kingdom Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 52.United Kingdom Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 53.United Kingdom Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 54.Russia Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 55.Russia Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 56.Russia Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 57.Russia Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 58.Russia Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 59.Netherlands Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 60.Netherlands Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 61.Netherlands Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 62.Netherlands Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 63.Netherlands Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 64.Spain Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Spain Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 66.Spain Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 67.Spain Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 68.Spain Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 69.Turkey Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 70.Turkey Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 71.Turkey Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 72.Turkey Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 73.Turkey Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 74.Poland Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 75.Poland Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 76.Poland Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 77.Poland Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 78.Poland Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 79.South America Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 80.South America Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 81.South America Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 82.South America Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 83.South America Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 84.South America Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
  • Figure 85.Brazil Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 86.Brazil Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 87.Brazil Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 88.Brazil Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 89.Brazil Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 90.Argentina Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 91.Argentina Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 92.Argentina Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 93.Argentina Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 94.Argentina Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 95.Asia-Pacific Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 96.Asia-Pacific Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 97.Asia-Pacific Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 98.Asia-Pacific Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 99.Asia-Pacific Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 100.Asia-Pacific Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
  • Figure 101.India Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.India Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 103.India Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 104.India Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 105.India Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 106.China Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 107.China Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 108.China Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 109.China Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 110.China Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 111.Japan Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 112.Japan Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 113.Japan Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 114.Japan Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 115.Japan Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 116.Australia Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 117.Australia Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 118.Australia Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 119.Australia Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 120.Australia Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 121.Vietnam Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 122.Vietnam Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 123.Vietnam Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 124.Vietnam Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 125.Vietnam Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 126.South Korea Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.South Korea Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 128.South Korea Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 129.South Korea Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 130.South Korea Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 131.Indonesia Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 132.Indonesia Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 133.Indonesia Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 134.Indonesia Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 135.Indonesia Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 136.Philippines Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 137.Philippines Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 138.Philippines Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 139.Philippines Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 140.Philippines Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 141.Middle East & Africa Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 142.Middle East & Africa Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 143.Middle East & Africa Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 144.Middle East & Africa Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 145.Middle East & Africa Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 146.Middle East & Africa Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
  • Figure 147.Saudi Arabia Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 148.Saudi Arabia Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 149.Saudi Arabia Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 150.Saudi Arabia Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 151.Saudi Arabia Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 152.UAE Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 153.UAE Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 154.UAE Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 155.UAE Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 156.UAE Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 157.South Africa Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
  • Figure 158.South Africa Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
  • Figure 159.South Africa Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
  • Figure 160.South Africa Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
  • Figure 161.South Africa Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
  • Figure 162.By Parasite Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163.By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164.By Treatment Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 166.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023